85 related articles for article (PubMed ID: 10728963)
1. Beta-blocker titration failure is independent of severity of heart failure.
Anthonio RL; van Veldhuisen DJ; Breekland A; Crijns HJ; van Gilst WH
Am J Cardiol; 2000 Feb; 85(4):509-12, A11. PubMed ID: 10728963
[TBL] [Abstract][Full Text] [Related]
2. Different effects of bisoprolol on heart rate in patients with ischemic or idiopathic dilated cardiomyopathy (a 24-hour Holter substudy of the Cardiac Insufficiency Bisoprolol Study [CIBIS]).
Anthonio RL; Brouwer J; Lechat P; Haaksma J; van der Ven L; van Veldhuisen DJ; Crijns HJ; van Gilst WH
Am J Cardiol; 1999 Apr; 83(8):1286-9, A10. PubMed ID: 10215303
[TBL] [Abstract][Full Text] [Related]
3. The role of beta-blockers in left ventricular dysfunction and heart failure.
Hjalmarson A; Kneider M; Waagstein F
Drugs; 1997 Oct; 54(4):501-10. PubMed ID: 9339958
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the calcium-blocking agent diltiazem in patients with heart failure due to dilated cardiomyopathy.
Suwa M; Ito T; Otake Y; Moriguchi A; Hirota Y; Kawamura K
Jpn Circ J; 1996 Oct; 60(10):767-73. PubMed ID: 8933239
[TBL] [Abstract][Full Text] [Related]
5. Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.
Hamaad A; Lip GY; Nicholls D; MacFadyen RJ
Cardiovasc Drugs Ther; 2007 Dec; 21(6):437-44. PubMed ID: 17896170
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effects of bisoprolol in congestive heart failure due to dilated cardiomyopathy].
Li Z; Li L
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):683-6. PubMed ID: 8731831
[TBL] [Abstract][Full Text] [Related]
7. Effects of bisoprolol treatment for chronic heart failure initiated and followed up by primary care physicians.
Schuchert A;
Eur J Heart Fail; 2005 Jun; 7(4):604-11. PubMed ID: 15921801
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta-blocker treatment in dilated cardiomyopathy with bradyarrhythmias.
Suwa M; Ito T; Otake Y; Kobashi A; Hirota Y; Kawamura K
Jpn Circ J; 1998 Oct; 62(10):765-9. PubMed ID: 9805259
[TBL] [Abstract][Full Text] [Related]
9. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
[TBL] [Abstract][Full Text] [Related]
10. Bisoprolol pilot studies in myocardial infarction.
de Muinck ED; Lie KI; von Mengden HJ; Reck R; Verkenne P
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S196-200. PubMed ID: 11527129
[TBL] [Abstract][Full Text] [Related]
11. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
Krum H; Bailey M; Meyer W; Verkenne P; Dargie H; Lechat P; Anker S
Cardiology; 2007; 108(1):28-34. PubMed ID: 16960445
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between the improvement of cardiac function and the myocardial uptake of I-123 metaiodobenzylguanidine in patients with dilated cardiomyopathy treated by beta-blocker].
Wakita T; Numata Y; Ogata Y; Harada E; Mizumasa Y
J Cardiol; 1995 Sep; 26(3):177-83. PubMed ID: 7473048
[TBL] [Abstract][Full Text] [Related]
13. Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine.
Raja DC; Kapoor A; Sinha A; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel P
Indian Heart J; 2018; 70(2):246-251. PubMed ID: 29716702
[TBL] [Abstract][Full Text] [Related]
14. Cardioselective beta blockade in hypertrophic cardiomyopathy.
Webb-Peplos MM; Croxson RS; Khanna P; Raphael MJ; Steiner RE; Oakley CM; Goodwin JF
Acta Cardiol; 1972; ():Suppl 15:263-7. PubMed ID: 4147610
[No Abstract] [Full Text] [Related]
15. Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Fukuchi K; Yasumura Y; Kiso K; Hayashida K; Miyatake K; Ishida Y
J Nucl Med; 2004 Apr; 45(4):527-31. PubMed ID: 15073245
[TBL] [Abstract][Full Text] [Related]
16. [Circulatory effects of prenalterol (selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Lu Quo Ging ; Guazzi M
Cardiologia; 1982; 27(1):99-101. PubMed ID: 6892381
[No Abstract] [Full Text] [Related]
17. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
Rhodes J; Margossian R; Darras BT; Colan SD; Jenkins KJ; Geva T; Powell AJ
Pediatr Cardiol; 2008 Mar; 29(2):343-51. PubMed ID: 17885779
[TBL] [Abstract][Full Text] [Related]
19. Effects of carvedilol on heart rate and blood pressure variability in subjects with chronic heart failure.
Piccirillo G; Luparini RL; Celli V; Moisè A; Lionetti M; Marigliano V; Cacciafesta M
Am J Cardiol; 2000 Dec; 86(12):1392-5, A6. PubMed ID: 11113424
[TBL] [Abstract][Full Text] [Related]
20. [Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol].
Belenkov IuN; Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Narusov OIu; Baklanova NA; Masenko VP
Kardiologiia; 2003; 43(10):10-21. PubMed ID: 14593351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
